SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-018692
Filing Date
2021-04-13
Accepted
2021-04-13 16:10:43
Documents
17
Period of Report
2021-04-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tptx-8k_20210409.htm   iXBRL 8-K 49482
2 EX-10.1 tptx-ex101_7.htm EX-10.1 245122
3 GRAPHIC g4v55vnpp42i000002.jpg GRAPHIC 44239
4 GRAPHIC g4v55vnpp42i000003.jpg GRAPHIC 7704
5 GRAPHIC g4v55vnpp42i000001.jpg GRAPHIC 8142
6 GRAPHIC g4v55vnpp42i000004.jpg GRAPHIC 7704
  Complete submission text file 0001564590-21-018692.txt   573186

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA tptx-20210409.xsd EX-101.SCH 5800
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE tptx-20210409_lab.xml EX-101.LAB 19673
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tptx-20210409_pre.xml EX-101.PRE 11652
10 EXTRACTED XBRL INSTANCE DOCUMENT tptx-8k_20210409_htm.xml XML 3575
Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 858-926-5251
Turning Point Therapeutics, Inc. (Filer) CIK: 0001595893 (see all company filings)

IRS No.: 463826166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38871 | Film No.: 21823186
SIC: 2834 Pharmaceutical Preparations